to have a high risk factor for treatment failure and relapse (Public Health Agency of Canada, 2015). However, researchers found that the combination of isoniazid, ethambutol, pyrazinamide and rifampin in highly effective in killing the bacilli completely and provides protection against relapse and resistance (Saeed, 2012). The client is taking all four medications thus, it is important to monitor for sign effects e.g. monthly blood work and vision test.
to have a high risk factor for treatment failure and relapse (Public Health Agency of Canada, 2015). However, researchers found that the combination of isoniazid, ethambutol, pyrazinamide and rifampin in highly effective in killing the bacilli completely and provides protection against relapse and resistance (Saeed, 2012). The client is taking all four medications thus, it is important to monitor for sign effects e.g. monthly blood work and vision test.